Department of Ophthalmology University Hospital, Dijon, FranceLaboratory of Toxicology, Faculty of Pharmaceutical and Biological Sciences, University of Paris-5 René Descartes, Paris, FranceEye and Nutrition Research Group, Centre des Sciences du Goût et de l'Alimentation, UMR 1324 INRA, 6265 CNRS, University of Burgundy, Dijon, France.
Acta Ophthalmol. 2014 Jun;92(4):364-9. doi: 10.1111/aos.12103. Epub 2013 Mar 18.
To determine whether tear osmolarity contributes to the assessment of the ocular surface in soft contact lens (CL) wearers.
Prospective, case-control series in 44 CL wearers (28 tolerant and 16 intolerant) and 34 healthy subjects. Every patient underwent a thorough ophthalmic examination with a tear osmolarity test (TearLab System), conjunctival impression cytology and meibomian lipid sampling. Symptoms, break-up time (BUT), tear osmolarity, conjunctival expression of HLA-DR and meibomian fatty acid composition were evaluated.
Tear osmolarity did not differ between controls and CL wearers (p= 0.23). Flow cytometry results expressed in antibody-binding capacity (ABC) units and percentage of positive cells revealed a significant difference between the intolerant CL wearer group and the control group (p< 0.0001). Comparisons between tolerant and intolerant CL wearers showed only a significant difference for mean fluorescence levels expressed in ABC units (p< 0.0001). The BUT was significantly shorter in intolerant and tolerant CL wearers subjects than in healthy subjects (p< 0.0001), whereas there was no significant difference in meibomian fatty acid composition (p= 0.99) between the two groups.
Contact lens wear is responsible for ocular surface alterations whose patterns are very similar to those reported in early dry-eye syndrome. However, tear osmolarity was not modified in these selected CL wearers. The yield of tear osmolarity with TearLab™ in assessing ocular surface disorders in CL wearers deserves further investigation.
确定泪液渗透压是否有助于评估软性隐形眼镜(CL)佩戴者的眼表面。
前瞻性、病例对照研究,纳入 44 名 CL 佩戴者(28 名耐受和 16 名不耐受)和 34 名健康受试者。每位患者均接受全面眼科检查,包括泪液渗透压测试(TearLab 系统)、结膜印迹细胞学和睑板腺脂质采样。评估症状、泪膜破裂时间(BUT)、泪液渗透压、结膜 HLA-DR 表达和睑板腺脂肪酸组成。
对照组和 CL 佩戴者的泪液渗透压无差异(p=0.23)。以抗体结合能力(ABC)单位和阳性细胞百分比表示的流式细胞术结果显示,不耐受 CL 佩戴者组与对照组之间存在显著差异(p<0.0001)。与耐受 CL 佩戴者相比,不耐受 CL 佩戴者的平均荧光水平表达在 ABC 单位上仅存在显著差异(p<0.0001)。不耐受和耐受 CL 佩戴者的 BUT 明显短于健康受试者(p<0.0001),而两组之间的睑板腺脂肪酸组成无显著差异(p=0.99)。
隐形眼镜的佩戴会导致眼表面发生改变,其模式与早期干眼症综合征报道的模式非常相似。然而,在这些选定的 CL 佩戴者中,泪液渗透压没有改变。TearLab™ 测量泪液渗透压在评估 CL 佩戴者眼表面疾病方面的效果值得进一步研究。